You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 4, July 23, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Benefits and Risks of Screening Mammography in Women With BRCA1 and BRCA2 Mutations-Reply

Wylie Burke, MD, PhD
University of Washington Seattle

Mary Daly, MD, PhD
Fox Chase Cancer Center Philadelphia, Pa

Judy Garber, MD, MPH
Dana-Farber Cancer Institute Boston, Mass

Jeffrey Botkin, MD, MPH
University of Utah Salt Lake City Mary Jo Ellis Kahn National Breast Cancer Coalition Richmond, Va

Patrick Lynch, MD,JD
University of Texas Houston

Anne McTiernan, MD, PhD
Fred Hutchinson Cancer Research Center Seattle, Wash

Kenneth Offit, MD, MPH
Memorial Sloan-Kettering Institute for Cancer Research New York, NY

Jeffrey A. Perlman, MD
Claudette Varricchio, DSN, RN National Cancer Institute Bethesda, Md

Gloria Petersen, PhD
The Johns Hopkins University Baltimore, Md

Elizabeth Thomson, MS, RN
National Human Genome Research Institute Bethesda, Md

JAMA. 1997;278(4):290.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We agree with Ms Gilson and Drs Vaidya and

Baum that there is a potential risk from mammography for women carrying BRCA1 and BRCA2 mutations, but we believe there is a greater likelihood of benefit. Vaidya and Baum note recent publications indicating a DNA repair function for the BRCA1 and BRCA2 protein1-3 and suggest that these observations raise questions about the use of screening mammography for individuals carrying mutations in these genes. While a defect in a DNA repair mechanism may increase the risk of radiation exposure, we believe it would be premature to conclude that individuals carrying BRCA1 or BRCA2 mutations will be "exquisitely sensitive to even small amounts of ionizing radiation." This research finding is preliminary and of uncertain clinical significance. It may mean that cancers associated with BRCA1 and BRCA2 mutations are more sensitive to radiation. Further, while mammography may pose risk, it also remains the . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.